Description
Tirzepatide is a synthetic peptide research compound that acts as a dual agonist at the GIP and GLP-1 receptors. It is studied as a reference compound for examining combined incretin signaling.
Reported investigations cover glucose homeostasis, insulin release, appetite-related behavioral endpoints, and dual receptor activation in cell and rodent systems. Its co-agonist design supports mechanistic study of incretin pathway interplay.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.